Last reviewed · How we verify
Shortened duration of antifungal therapy — Competitive Intelligence Brief
phase 3
Infectious Diseases
Small molecule
Live · refreshed every 30 min
Target snapshot
Shortened duration of antifungal therapy (Shortened duration of antifungal therapy) — Assistance Publique - Hôpitaux de Paris. Shortened duration of antifungal therapy is achieved by reducing the time required to treat fungal infections.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Shortened duration of antifungal therapy TARGET | Shortened duration of antifungal therapy | Assistance Publique - Hôpitaux de Paris | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Shortened duration of antifungal therapy CI watch — RSS
- Shortened duration of antifungal therapy CI watch — Atom
- Shortened duration of antifungal therapy CI watch — JSON
- Shortened duration of antifungal therapy alone — RSS
Cite this brief
Drug Landscape (2026). Shortened duration of antifungal therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/shortened-duration-of-antifungal-therapy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab